Effect of sacubitril/valsartan versus valsartan on blood pressure in hypertensive patients with chronic heart failure and chronic kidney disease, a parallel-group randomized controlled trial
Latest Information Update: 22 Sep 2022
At a glance
- Drugs Sacubitril/valsartan (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- Acronyms SaVa-CKD
- 22 Sep 2022 Status changed from recruiting to discontinued.
- 23 Mar 2021 New trial record